Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Top Cited Papers
- 30 September 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 8 (10), 823-833
- https://doi.org/10.1016/S2213-8587(20)30271-0
Abstract
No abstract availableFunding Information
- Merck Sharp and Dohme
- Novartis
- National Institute for Health and Care Research
- Sanofi
- Diabetes UK
- Eli Lilly and Company
- Novo Nordisk
- Pfizer
- NIHR Leicester Biomedical Research Centre
- Boehringer Ingelheim
This publication has 20 references indexed in Scilit:
- Obesity Is a Risk Factor for Severe COVID-19 InfectionCirculation, 2020
- Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regressionDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Commentary: COVID-19 and diabetesDiabetes Research and Clinical Practice, 2020
- COVID-19 and smoking: A systematic review of the evidenceTobacco Induced Diseases, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort StudyDiabetes Care, 2018
- Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort StudyDiabetes Care, 2018
- Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic SubgroupsDiabetes Care, 2016
- Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2016
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006